SC
IRMD icon

Sophrosyne Capital’s iRadimed IRMD Stock Holding History

Sophrosyne Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-68,751
Closed -$1.6M – 11
2015
Q2 		$1.6M Sell
68,751
-270,407
-80% -$4.94M 11.98% 3
2015
Q1 		$5.17M Sell
339,158
-10,142
-3% -$150K 8.87% 2
2014
Q4 		$4.5M Sell
349,300
-29,471
-8% -$254K 6.95% 3
2014
Q3 		$2.65M Buy
+378,771
New +$3.43M 3.13% 9

Other funds holding IRMD

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Sophrosyne Capital's IRMD Position: Q3 2015 in Review

Sophrosyne Capital sold out of iRadimed (IRMD) in Q3 2015, closing a stake of 68,751 shares — an estimated $1.6M sold.

Sophrosyne Capital first reported a position in IRMD in Q3 2014 and held it in 4 quarters. The position peaked at $5.17M in Q1 2015. 47 funds tracked by Wall St. Rank hold IRMD as of Q3 2015.

  • Sophrosyne Capital reported no remaining iRadimed position as of Q3 2015 after selling out during the quarter.
  • Sophrosyne Capital sold 68,751 iRadimed shares in Q3 2015, an estimated $1.6M.
  • Sophrosyne Capital first reported a position in iRadimed in Q3 2014 and held it in 4 quarters.
  • Sophrosyne Capital's iRadimed position peaked at $5.17M in Q1 2015.
  • 47 funds tracked by Wall St. Rank held iRadimed as of Q3 2015.

Based on Sophrosyne Capital's 13F filing for Q3 2015, filed 13 Nov 2015.